420
Participants
Start Date
August 31, 2011
Primary Completion Date
October 31, 2013
Study Completion Date
November 30, 2013
Fimasartan , Amlodipine, Placebo
Fimasartan 60mg, Fimasartan 30mg, Amlodipine 5mg, Amlodipine 10mg, Placebo, Fimasartan 60mg/Amlodipine 5mg combination, Fimasartan 60mg/Amlodipine 10mg combination, Fimasartan 30mg/Amlodipine 5mg combination, Fimasartan 30mg/Amlodipine 10mg combination
Samsung Medical Center, Seoul
Lead Sponsor
Collaborators (1)
Gachon University Gil Medical Center
OTHER
The Catholic University of Korea
OTHER
Kyungpook National University Hospital
OTHER
Daegu Catholic University Medical Center
OTHER
Wonkwang University Hospital
OTHER
Wonju Severance Christian Hospital
OTHER
Korea University Guro Hospital
OTHER
DongGuk University
OTHER
Yeungnam University Hospital
OTHER
Chonnam National University Hospital
OTHER
Cheil General Hospital and Women's Healthcare Center
OTHER
Chungnam National University
OTHER
Asan Medical Center
OTHER
Seoul National University Bundang Hospital
OTHER
Inha University Hospital
OTHER
Seoul National University Hospital
OTHER
Inje University
OTHER
Samsung Medical Center
OTHER
Busan National University Yangsan Hospital
UNKNOWN
Soon Chun Hyang University
OTHER
Catholic University of Korea Saint Paul's Hospital
OTHER
Hallym University Kangnam Sacred Heart Hospital
OTHER
Jeju National University Hospital
OTHER
Hanyang University Seoul Hospital
OTHER
Kangbuk Samsung Hospital
OTHER
Boryung Pharmaceutical Co., Ltd
INDUSTRY